Skip to main content
Better survival in aggressive NHL found with PET/CT-guided treatment

Individuals with aggressive non-Hodgkin lymphoma and those with limited-stage Hodgkin lymphoma who underwent PET/CT-guided therapy had reduced one-year mortality, compared with those who had CT-guided treatment only, but those with HL had similar one-year outcomes, Canadian researchers reported in a radiology journal. The findings prompted researchers to suggest the association between PET-directed patient management and improved overall outcomes among those with ANHL.

Full Story: